Skip to main content

Table 7 Comparisons of ROM between curcumin supplement and placebo

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author Curcumin Placebo
N Mean SD N Mean SD
(a) ROM preexercise
Tanabe Y 14 134 4 14 133 5
Tanabe Y 8 136.47 4.71 8 135.69 7.84
Tanabe Y (pre) 10 133.85 9.24 10 133.85 6.16
Tanabe Y (post) 10 136.92 6.93 10 133.85 6.93
UMD (95% CI)     1.18 (− 1.30, 3.67)   
(b) ROM post-exercise
Tanabe Y 14 115.03 12.64 14 112.31 12.64
Tanabe Y 8 116.86 6.27 8 110.59 16.47
Tanabe Y (pre) 10 116.2 5.39 10 117.69 3.08
Tanabe Y (post) 10 119.28 110.77 10 110.04 12.32
UMD (95% CI)      − 0.30 (− 3.71, 3.11)   
(c) ROM at 24 h
Tanabe Y 14 116.76 12.07 14 113.46 9.196
Tanabe Y 8 112.98 10.98 8 113.73 11.76
Tanabe Y (pre) 10 109.23 5.39 10 112.31 9.23
Tanabe Y (post) 10 119.28 9.23 10 108.5 11.55
UMD (95%CI)     2.30 (− 3.78, 8.37)   
(d) ROM at 48 h
Tanabe Y 14 118.48 12.64 14 114.03 8.62
Tanabe Y 8 106.67 12.55 8 105.88 14.11
Tanabe Y (pre) 10 103.11 6.16 10 107.69 12.31
Tanabe Y (post) 10 118.51 9.23 10 100.8 13.08
UMD (95%CI)     4.57 (− 4.85, 14.00)
4.57 (− 4.85, 14.00)
  
(e) ROM at 72 h
Tanabe Y 14 119.06 12.64 14 114.61 14.94
Tanabe Y 8 106.67 17.25 8 98.04 15.69
Tanabe Y (pre) 10 106.19 16.94 10 103.85 14.62
Tanabe Y (post) 10 120.05 10.77 10 96.95 15.38
UMD (95%CI)     9.84 (− 0.02, 19.70)   
(f) ROM at 96 h
Tanabe Y 14 122.51 11.49 14 116.33 11.49
Tanabe Y 8 109.8 18.82 8 103.53 10.98
Tanabe Y (pre) 10 110.04 9.24 10 110.77 16.16
Tanabe Y (post) 10 123.85 9.23 10 103.88 10.77
UMD (95%CI)     8.45 (− 0.84, 17.74)